Expression of the human telomerase reverse transcriptase in pheochromocytoma and neuroblastoma tissues.
In an effort to clarify the role of telomerase in the pathogenesis of pheochromocytomas and neuroblastomas, and to test whether its component could serve as a marker of malignancy, we measured telomerase reverse transcriptase (TERT) mRNA in 31 human pheochromocytoma tissue samples (5 malignant, 23 benign and 3 suspected malignant) and 16 neuroblastoma tissues (9 unfavorable and 7 favorable). All cases were classified by both the clinical course and histopathological examination. Malignancy was defined as the presence of metastasis and/or extensive local invasion. TERT mRNA was determined by nested PCR and a real-time PCR system (LightCycler). By nested PCR methods, 5 of the 5 malignant pheochromocytoma samples were positive (sensitivity = 100%), and 21 of 23 benign pheochromocytoma samples were negative (specificity = 91%) in pheochromocytomas. Four out of five malignant tumors were positive for either hTERT expression or Ki-67/MIB-1 immunoreactivity. In the neuroblastoma tissues, 9 of the 9 unfavorable samples were positive (sensitivity = 100%), and only 2 of 7 favorable samples were negative (specificity = 29%). We also determined the expression of the hTERT mRNA by real-time PCR to quantitate the mRNA. The mean values of hTERT mRNA by real time PCR in benign and malignant pheochromocytomas were 2 and 26 arbitrary units (AU), respectively. The difference was not significant by the U-test. The mean values of hTERT mRNA in favorable and unfavorable neuroblastoma were 203 and 497 AU, respectively. This difference was also not significant (U-test). N-Myc mRNA expression correlated with the expression of hTERT mRNA in the neuroblastoma samples (r = 0.534, p = 0.0317). Thus, hTERT mRNA might be a potential marker for estimating the malignancy of pheochromocytomas and neuroblastomas.
Isobe
Kazumasa
K
Department of Clinical Pathology, University of Tsukuba, Ibaraki, Japan.
Yashiro
Toru
T
Omura
Sakie
S
Kaneko
Michio
M
Kaneko
Setsuko
S
Kamma
Hiroshi
H
Tatsuno
Ichiro
I
Takekoshi
Kazuhiro
K
Kawakami
Yasushi
Y
Nakai
Toshiaki
T
D000293:Adolescent; D000310:Adrenal Gland Neoplasms / Q000201:enzymology*; D000328:Adult; D000368:Aged; D002675:Child, Preschool; D004268:DNA-Binding Proteins; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D007223:Infant; D019394:Ki-67 Antigen / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D009447:Neuroblastoma / Q000201:enzymology*; D010673:Pheochromocytoma / Q000201:enzymology*; D012333:RNA, Messenger / Q000378:metabolism; D019098:Telomerase / Q000235:genetics / Q000378:metabolism*
D004268:DNA-Binding Proteins; D019394:Ki-67 Antigen; D012333:RNA, Messenger; C509186:TERT protein, human; D019098:Telomerase